Hemostemix Market Cap

Hemostemix has a market cap or net worth of CAD 15.62 million as of March 9, 2026. Its market cap has decreased by -44.75% in one year.

Market Cap

15.62M

Enterprise Value

17.76M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.09

Market Cap Chart

Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 15.62M, a decrease of -68.04%. That is a compound annual growth rate of -9.62%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	15.62M	-11.11%
Dec 31, 2025	17.57M	3.39%
Dec 31, 2024	17.00M	178.71%
Dec 29, 2023	6.10M	-55.27%
Dec 30, 2022	13.63M	44.06%
Dec 31, 2021	9.46M	-70.84%
Dec 31, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lobe Sciences	16.17M
Rapid Dose Therapeutics	16.22M
Britannia Life Sciences	17.85M
Quantum BioPharma	18.21M
Innovotech	13.26M
Pharmala Biotech Holdings	11.98M
PreveCeutical Medical	11.96M
Thiogenesis Therapeutics	25.92M

Market Cap Rankings